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The story of baby Gammy and his “surrogate” mother has captured the world’s attention, highlighting 
just how complex and fraught commercial surrogacy arrangements can be. It also shows Australia is 
right to prohibit commercial surrogacy – and why other countries should do the same.
Gammy was born with Down syndrome and a congenital heart condition. He is a twin, conceived as a 
result of a commercial surrogacy arrangement between an unidentified Australian couple (the
“genetic parents”) and Pattaramon Chanbua, a Thai national whose family was struggling to pay off 
debts. Ms Chanbua was paid 350,000 baht (A$11,700) to carry and bear a child.
According to Ms Chanbua, when it was discovered she was carrying twins, she was offered an 
additional 70,000 Baht (A$2,000). But when doctors further discovered one of the babies had Down 
syndrome, she was told to abort the affected twin. She refused on religious grounds and, after the 
twins’ birth, the Australian couple left with only the healthy girl.
The Australian father has since claimed the couple did not know about the other child. But Ms
Chanbua states the father came to the hospital to see the twins. It’s unclear what role the surrogacy
agency played.
However it played out, baby Gammy was left with Ms Chanbua, who loves and cares for him, but
struggles to pay his medical expenses. The story has attracted international outrage, and a public 
campaign to raise money for baby Gammy’s care.
The legal situation
The majority of nations that regulate surrogacy worldwide, prohibit commercial surrogacy. Such
prohibitions are largely based on views that commercial surrogacy commodifies women and children,
and poses an unacceptable risk of exploitation and human trafficking.
All Australian states and the Australian Capital Territory prohibit such arrangements here. New South
Wales, Queensland and the ACT further prohibit people from travelling to other countries to engage
in such practices. The Australian government lists these prohibitions in its reports to the United
Nations to show we meet our international obligations against the sale and trafficking of children.
However, a minority of nations have allowed (or continue to allow) commercial surrogacy to occur:
Guatemala, Russia, the Ukraine, India and some US states. As a consequence, brokers, lawyers, and
clinics have encouraged people wishing to have children to travel to such destinations to “realise their
dreams” of having a family.
At the time of the arrangement that resulted in Gammy’s birth, draft laws in Thailand had not yet
been enacted, and the practice appears to have been unregulated. Thailand was seen as a particularly
favourable destination as the cost was also low, compared to the United States, for example, where
surrogacy can cost up to $100,000.
When things go wrong
Some people who engage in commercial surrogacy are already breaking the law in their own country.
Others have found themselves in complex situations where the legal parentage and citizenship of the
children is unclear.
In addition, people who remove children from Thailand without the approval of the Thai government
would be subject to Thai anti-trafficking laws.
The baby Gammy story also highlights human rights issues in commercial surrogacy arrangements.
Note that the request for Ms Chanbua to have an abortion would have been illegal in Thailand, unless
her health was at risk, or the pregnancy was a consequence of sexual assault. Neither appears to have
been the case.
People trafficking Surrogacy Gammy
Ms Chanbua refused on religious grounds, and by choice carried the pregnancy to term. But other
women may not be able to do the same. In India, some women are required to sign a contract
agreeing that they will abort on demand.
No room for commercial surrogacy
Some surrogate advocates, lawyers and agencies argue that it would be better to permit commercial
surrogacy in Australia, as if we could somehow prevent exploitation and commodification, as well as
the social, cultural, economic and racial disparities.
Some point to the “happy stories” of surrogacy fulfilling the dreams of would-be parents of having a
family. And no doubt, there are families who must be happy having had a child they can call their
“own”.
But what we must not forget are the realities of this “business”. We so often do not hear about the
number of abortions it took to get the final product right, or the miscarriages, the early births, the
pregnancy complications, the babies left behind, or the reasons why the surrogate entered the
arrangement for money in the first place. Whenever commercial surrogacy takes place, there are risks
and power imbalances.
When the surrogacy “support services” refer to “the market” in which they operate, we, as a nation,
should stop and think. We must not ignore the extent to which commercial surrogacy arrangements
can exploit and commodify women and children. We might also think about how such a business 
preys on people’s desires to have children.
While baby Gammy’s story certainly calls for government support and action, the focus should not be
on how to support the commercial surrogacy “market”, or to broaden the “market” to Australia.
Rather, we should focus on how to protect the rights and welfare of children and women in line with
global human rights standards. This includes the continued prohibition of commercial surrogacy
arrangements.
